DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,985,909 | -1.5% | 24,127 | -4.8% | 0.12% | +1.6% |
| Q2 2023 | $6,079,440 | +5.8% | 25,331 | +11.1% | 0.12% | 0.0% |
| Q1 2023 | $5,744,748 | -19.0% | 22,793 | -14.7% | 0.12% | -24.2% |
| Q4 2022 | $7,091,492 | +19.8% | 26,718 | +16.6% | 0.16% | +16.7% |
| Q3 2022 | $5,917,000 | +0.8% | 22,908 | -1.1% | 0.14% | +9.5% |
| Q2 2022 | $5,872,000 | +11.9% | 23,162 | +29.4% | 0.13% | +32.6% |
| Q1 2022 | $5,249,000 | -4.0% | 17,896 | +7.7% | 0.10% | -1.0% |
| Q4 2021 | $5,465,000 | +7.9% | 16,610 | -0.1% | 0.10% | +1.1% |
| Q3 2021 | $5,063,000 | +15.8% | 16,630 | +2.1% | 0.10% | +21.8% |
| Q2 2021 | $4,372,000 | -0.9% | 16,292 | -16.9% | 0.08% | -11.4% |
| Q1 2021 | $4,411,000 | +2.5% | 19,597 | +1.2% | 0.09% | -3.3% |
| Q4 2020 | $4,304,000 | +2.4% | 19,373 | -0.8% | 0.09% | -13.3% |
| Q3 2020 | $4,204,000 | -1.6% | 19,525 | -19.2% | 0.10% | -5.4% |
| Q2 2020 | $4,273,000 | +27.1% | 24,164 | -0.5% | 0.11% | +8.8% |
| Q1 2020 | $3,363,000 | +0.3% | 24,296 | +11.2% | 0.10% | +22.9% |
| Q4 2019 | $3,354,000 | +6.7% | 21,851 | +0.4% | 0.08% | -3.5% |
| Q3 2019 | $3,144,000 | +9.5% | 21,767 | +8.3% | 0.09% | +10.3% |
| Q2 2019 | $2,871,000 | -2.2% | 20,090 | -9.6% | 0.08% | 0.0% |
| Q1 2019 | $2,935,000 | +21.2% | 22,228 | -5.4% | 0.08% | +2.6% |
| Q4 2018 | $2,422,000 | -10.7% | 23,486 | -5.9% | 0.08% | +10.1% |
| Q3 2018 | $2,712,000 | +0.4% | 24,959 | -8.8% | 0.07% | -5.5% |
| Q2 2018 | $2,702,000 | +16.3% | 27,377 | +15.4% | 0.07% | +21.7% |
| Q1 2018 | $2,323,000 | -2.8% | 23,729 | -7.9% | 0.06% | -3.2% |
| Q4 2017 | $2,391,000 | +9.4% | 25,754 | +1.1% | 0.06% | +5.1% |
| Q3 2017 | $2,186,000 | -22.9% | 25,479 | -24.2% | 0.06% | -24.4% |
| Q2 2017 | $2,836,000 | -2.5% | 33,603 | -1.2% | 0.08% | -4.9% |
| Q1 2017 | $2,910,000 | +15.3% | 34,021 | +4.9% | 0.08% | +12.3% |
| Q4 2016 | $2,523,000 | +15.7% | 32,418 | +16.5% | 0.07% | +14.1% |
| Q3 2016 | $2,181,000 | -23.1% | 27,828 | -0.9% | 0.06% | -24.7% |
| Q2 2016 | $2,837,000 | -0.2% | 28,094 | -6.3% | 0.08% | -1.2% |
| Q1 2016 | $2,844,000 | +3.3% | 29,977 | +1.1% | 0.09% | +4.9% |
| Q4 2015 | $2,754,000 | +8.3% | 29,652 | -0.6% | 0.08% | +6.5% |
| Q3 2015 | $2,542,000 | +3.3% | 29,826 | +3.7% | 0.08% | +13.2% |
| Q2 2015 | $2,460,000 | -5.6% | 28,748 | -6.3% | 0.07% | -4.2% |
| Q1 2015 | $2,606,000 | -2.0% | 30,693 | -1.1% | 0.07% | -6.6% |
| Q4 2014 | $2,660,000 | +7.7% | 31,040 | -4.5% | 0.08% | +4.1% |
| Q3 2014 | $2,470,000 | -4.1% | 32,514 | -0.6% | 0.07% | -5.2% |
| Q2 2014 | $2,575,000 | -8.5% | 32,722 | -12.7% | 0.08% | -8.3% |
| Q1 2014 | $2,813,000 | -3.9% | 37,500 | -1.1% | 0.08% | -10.6% |
| Q4 2013 | $2,927,000 | +4.6% | 37,916 | -6.0% | 0.09% | -4.1% |
| Q3 2013 | $2,797,000 | +31.8% | 40,342 | +20.3% | 0.10% | +19.5% |
| Q2 2013 | $2,122,000 | – | 33,533 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |